All the events here are relevant to people working in dementia research. If you would like to add your own you can submit an event
NAMs Technology Partn3Ring webinar
May 6 @ 2:00 pm - 3:15 pm
The second NAMs session will include presentations from researchers working across human relevant in vitro technologies, ranging from brain tumour modelling, stem cell platforms in toxicity and imaging, cell-based assays in safety assessment and organ function studies.
Amrita Singh (Integral Molecular)
• Human-relevant membrane proteome array to assess off-target binding of antibody-based therapies early in development.
• Seeking new users of technology to focus on expanding 3Rs benefits.
Davide Danovi (Migration Biotherapeutics)
• Human iPSC-based neural spheroid platform modelling tumour-brain interactions in glioblastoma.
• Looking for collaborators to further develop the model and quantify cancer cell migration.
Ciara Doran (Sansanima Limited)
• Non-animal, cell‑based assays for safety and potency testing of Clostridials.
• Seeking partners for quality, process control or next generation development of botulinum toxin.
James L. Sherley (Asymmetrex® LLC)
• Rapid, accurate counting and monitoring of tissue stem cells in heterogeneous tissue cell preparations in in vitro drug toxicity assessment.
• Seeking collaborators to help assess predictive value of technology in drug candidates known to cause chronic organ failure.
Jiwu Wang (Allele Biotechnology)
• Bioprinted iPSC derived liver mini-organs to replace in vivo organ function studies in drug development.
• Seeking teams with liver specific assay expertise to further qualify the model in longitudinal studies.
Register
